AstraZeneca (AZN:LSE) Annual Reports & Investor Relations Material

Overview

AstraZeneca PLC, the biopharmaceutical giant, is dedicated to the research, development, manufacturing, and commercialization of prescription medicines. The company has a diverse range of marketed products in its portfolio including drugs for oncology, cardiovascular, renal, and metabolism diseases, immunology, respiratory diseases, rare diseases, and even a vaccine for Covid-19. Its distribution network includes distributors and local representative offices worldwide. AstraZeneca has collaboration agreements with Neurimmune AG and Personalis, Inc. and was formerly known as Zeneca Group PLC before it changed its name in 1999. The company was founded in 1992 and is headquartered in Cambridge, UK.

Frequently Asked Questions

What is AstraZeneca's ticker?

AstraZeneca's ticker is AZN

What exchange is AstraZeneca traded on?

The company's shares trade on the LSE stock exchange

Where are AstraZeneca's headquarters?

They are based in Cambridge, England

How many employees does AstraZeneca have?

There are 10,000+ employees working at AstraZeneca

What is AstraZeneca's website?

It is astrazeneca.com

What type of sector is AstraZeneca?

AstraZeneca is in the Healthcare sector

What type of industry is AstraZeneca?

AstraZeneca is in the Drug Manufacturers - Major industry

Who are AstraZeneca's peers and competitors?

The following five companies are AstraZeneca's industry peers:

- GW Pharmaceuticals plc

- Eli Lilly and Company

- Sanofi

- Tricida

- Hikma Pharmaceuticals